Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Toshihiko Nishiyama"'
Autor:
Shinji Ichimori, Shinsuke Iwashita, Wakana Sakamoto, Eiichi Araki, Kenro Nishida, Taiji Sekigami, Masaji Sakaguchi, Norio Ishii, Ayaka Hokamura, Seiya Shimoda, Yasuto Matsuo, Ryohei Yoshimura, Kae Otsu, Toshihiko Nishiyama
Publikováno v:
Endocrine journal. 66(8)
To examine the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) or once-daily second-generation basal insulin analogs (insulin degludec and insulin glargine 300 units/mL) in insulin-naive Japanese adults with type 2 diabete
Autor:
Yoko Matsunaga, Seiji Ogawa, Hisao Nakai, Yutaka Okada, Atsushi Shimabukuro, Kohki Tsukamoto, Fumio Nambu, Atsushi Kinoshita, Rie Oumi, Yoshihiko Odagaki, Ryoji Matsumoto, Atsushi Naganawa, Jun Katagi, Maki Iwahashi, Koji Yano, Masaaki Toda, Toshihiko Nishiyama, Kousuke Tani
Publikováno v:
Bioorganic & Medicinal Chemistry. 19:6935-6948
To identify an orally available drug candidate, a series of 3-benzoylaminophenylacetic acids were synthesized and evaluated as prostaglandin D2 (PGD2) receptor antagonists. Some of the compounds tested were found to exhibit excellent inhibitory activ
Autor:
Kenji Maeda, Shiro Shibayama, Katsuya Hisaichi, Hideaki Tada, Yoshikazu Takaoka, Chiaki Minamoto, Toshihiko Nishiyama, Kenji Sagawa, Hiromu Habashita, Masaaki Toda, Rena Nishizawa, Naoki Matsunaga, Daikichi Fukushima, Hiroaki Mitsuya
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:727-731
Hydroxylated derivatives were designed and synthesized based on the information of oxidative metabolites. Compounds derived from β-substituted (2 R ,3 R )-2-amino-3-hydroxypropionic acid showed improved inhibitory activities against the binding of M
Autor:
Seiya Shimoda, Wakana Sakamoto, Ayaka Hokamura, Yasuto Matsuo, Taiji Sekigami, Shinji Ichimori, Shinsuke Iwashita, Norio Ishii, Kae Otsu, Ryohei Yoshimura, Toshihiko Nishiyama, Masaji Sakaguchi, Kenro Nishida, Eiichi Araki
Publikováno v:
Endocrine Journal; 2019, Vol. 66 Issue 8, p745-752, 8p
Autor:
Yshihiko Odagaki, Atsuko Fujii, Toshihiko Nishiyama, Masaaki Toda, Masaharu Komeno, Hisao Nakai, Tadashi Tatsumi, Masayuki Murota, Katsuya Hisaichi, Kaoru Kobayashi, Keisuke Hirai, Masao Naka, Yasufumi Kawanaka, Shinya Kusuda
Publikováno v:
Bioorganic & Medicinal Chemistry. 11:1723-1743
Further chemical modification of 2-iminopiperidines fused to cyclopropane rings was performed. Optically active isomers 2 and 13 were synthesized and their biological activity was evaluated. Compound 2 exhibited greater potency and more isoform selec
Autor:
Masao Naka, Katsuya Hisaichi, Atsuko Fujii, Masayuki Murota, Hisao Nakai, Tadashi Tatsumi, Keisuke Hirai, Minoru Nishizaki, Yasufumi Kawanaka, Masaharu Komeno, Kaoru Kobayashi, Masaaki Toda, Toshihiko Nishiyama, Shinya Kusuda
Publikováno v:
Bioorganic & Medicinal Chemistry. 11:689-702
The process of discovery and biological evaluation of alpha,beta-unsaturated cyclic amidines, as selective inhibitors of inducible nitric oxide synthase (iNOS), is reported. Dihydropyridin-2(1H)-imines and 1,5,6,7-tetrahydro-2H-azepin-2-imines were s
Publikováno v:
Tetrahedron. 53:3073-3082
In the reduction of ketones with NADH mimics, ( S S )-1-substituted 3-( p -tolylsulfinyl)-1,4-dihydropyridines 1 , the stereospecific transfer of one of the C-4 hydrogens, which is syn to the SO bond, was experimentally revealed to be involved by
Autor:
Takeshi Imanishi, Chuzo Iwata, Toshihiko Nishiyama, Satoshi Obika, Kazuyuki Miyashita, S. Tatematsu
Publikováno v:
Tetrahedron. 53:593-602
The reactions of the novel NADH model compounds 2 with methyl benzoylformate and some other ketonic compounds were studied. The 3-( p -tolylsulfinyl) derivaties 2 successfully reduced methyl bezoylformate to give methyl ( R )-mandelate in good chemic
Autor:
Takeshi Imanishi, Yoshimitsu Hamano, Kazuyuki Miyashita, Chuzo Iwata, Satoshi Obika, M. Nishimoto, Toshihiko Nishiyama
Publikováno v:
Chemical and Pharmaceutical Bulletin. 44:267-272
Novel NADH model compounds, (SS)-1-alkyl-3-(p-tolylsulfinyl)-1, 4-dihydropyridines (2) and (RS)-1-benzyl-3-[1-oxo-2-(p-tolylsulfinyl)ethyl]-1, 4-dihydropyridine (3), were synthesized. 1H-NMR study and X-ray analysis of 2 revealed its preferred confor
Autor:
Toshihiko Nishiyama, Yoshikazu Takaoka, Hisao Nakai, Katsuya Hisaichi, Kenji Sagawa, Kenji Maeda, Chiaki Minamoto, Shiro Shibayama, Masayuki Murota, Daikichi Fukushima, Hideaki Tada, Hiroaki Mitsuya, Rena Nishizawa
Publikováno v:
Bioorg Med Chem
Based on the original spirodiketopiperazine design framework, further optimization of an orally available CCR5 antagonist was undertaken. Structural hybridization of the hydroxylated analog 4 derived from one of the oxidative metabolites and the new